Z75.8 I10.9 R73.9 E14 E78.5 D64.9
Conditions
Interventions
Group 1: Arm 1 - High labeled cash transfer (LCT): 1000 CFA (~US$2) to cover incidental costs related to a needed healthcare facility visit.
Group 2: Arm 2 - Low labeled cash transfer (LCT): 500 CFA
Sponsors
Heidelberg Institute of Public Health
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: A primary resident of the household for at least the preceding six months; Willing and able to give informed consent to participate in the Centre de Recherche en Santé de Nouna (CRSN) Heidelberg Aging Study, including either completing a blood pressure measurement or provide a whole blood sample; Being found to have at least one of the following risk factors: Low density lipoprotein > 160mg/dL (4.1 mmol/L), Hemoglobin 6.5%, Hyperglycemia >126mg/dL if participant reports to have fasted or >200mg/dL if participant reports that he has eaten or drunk in the last 6 hours before testing, Systolic blood pressure > 140 or diastolic blood pressure > 90
Exclusion criteria
Exclusion criteria: Withdrawal of consent; Persistent display of distress by the participant; Inability of participant to follow study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints: Within 3 months of the home visit 1.Linkage to care: any clinic visit (measured by the return of the referral card that was provided to participants at the time of the home visit that identified need for care and treatment of a chronic condition) 2.Treatment uptake: any counselling or medication or other intervention received at a clinic (measured by healthcare providers’ responses to multiple-choice questions on the referral card) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: Within 3 months of the home visit 1.Any physical or biological examination received at a clinic and recorded 2.Any counselling received 3.Any medication received 4.Any other intervention received 5.Any counselling or medication or other intervention received for hypertension 6.Any counselling received for hypertension 7.Any medication received for hypertension 8.Any other intervention received for hypertension 9.Any counselling or medication or other intervention received for diabetes/hyperglycemia 10.Any counselling received for diabetes/hyperglycemia 11.Any medication received for diabetes/hyperglycemia 12.Any other intervention received for diabetes/hyperglycemia 13.Any counselling or medication or other intervention received for hyperlipidemia 14.Any counselling received for hyperlipidemia 15.Any medication received for hyperlipidemia 16.Any other intervention received for hyperlipidemia 17.Any counselling or medication or other intervention received for anemia 18.Any counselling received for anemia 19.Any medication received for anemia 20.Any other intervention received for anemia All of the secondary endpoints above will be assessed using healthcare providers’ responses to multiple-choice questions on the referral card. In addition, we will assess two further secondary endpoints in the next routine household survey (the exact time of which has not yet been decided), which will be conducted as part of the ongoing health and demographic surveillance in the area in which the trial is taking place. These endpoints are: 1. Self-reporting to be taking medication (yes/no) prescribed by a healthcare worker for the NCD risk factor(s) for which the participant received the referral card 2. The continuous value of the measurement for the NCD risk factor(s) for which the participant received the referral card (i.e., blood pressure for those who were referred for hypertension; HbA1c and blood glucose for diabetes; total | — |
Countries
Burkina Faso
Contacts
Public ContactAli Sié
Centre for Research on Health in Nouna (CRSN)
Outcome results
None listed